136 related articles for article (PubMed ID: 7484527)
1. [E-cadherin expression and histopathological features in renal cell carcinomas].
Jin TX; Kakehi Y; Moroi S; Yoshida O
Hinyokika Kiyo; 1995 Sep; 41(9):653-7. PubMed ID: 7484527
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
3. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
4. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
6. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
[TBL] [Abstract][Full Text] [Related]
7. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin expression in normal kidney tissue and renal carcinomas.
Dagli AF; Aydin S; Karaoglu A; Akpolat N; Ozercan IH; Ozercan MR
Pathol Res Pract; 2009; 205(3):165-73. PubMed ID: 19054628
[TBL] [Abstract][Full Text] [Related]
9. Genetic changes of the E-cadherin and APC tumour suppressor genes in clear cell renal cell carcinoma.
Pećina-SLaus N; Gall-TroSelj K; SLaus M; Radić K; NikuSeva-Martić T; Pavelić K
Pathology; 2004 Apr; 36(2):145-51. PubMed ID: 15203750
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of caveolin-1 in renal neoplasms.
Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
[TBL] [Abstract][Full Text] [Related]
11. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
12. Parvalbumin is constantly expressed in chromophobe renal carcinoma.
Martignoni G; Pea M; Chilosi M; Brunelli M; Scarpa A; Colato C; Tardanico R; Zamboni G; Bonetti F
Mod Pathol; 2001 Aug; 14(8):760-7. PubMed ID: 11504835
[TBL] [Abstract][Full Text] [Related]
13. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
[TBL] [Abstract][Full Text] [Related]
14. Cadherins in renal cell carcinoma.
Heicappell R
Anticancer Res; 1999; 19(2C):1501-4. PubMed ID: 10365132
[TBL] [Abstract][Full Text] [Related]
15. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB
Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
17. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
18. Vinculin: its possible use as a marker of normal collecting ducts and renal neoplasms with collecting duct system phenotype.
Kuroda N; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Moriki T; Yamasaki Y; Numoto S; Yamamoto Y; Yamasaki I; Hiroi M; Shuin T; Enzan H
Mod Pathol; 2000 Oct; 13(10):1109-14. PubMed ID: 11048805
[TBL] [Abstract][Full Text] [Related]
19. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
20. Different immunohistochemical patterns of Fhit protein expression in renal neoplasms.
Eyzaguirre EJ; Miettinen M; Norris BA; Gatalica Z
Mod Pathol; 1999 Oct; 12(10):979-83. PubMed ID: 10530564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
